The Effect of Folic Acid-Targeted Nanocarriers in Ultrasound Imaging-guided Sonodynamic Therapy of Human Cervical Carcinoma (HeLa): in vitro Study

authors:

avatar Roghayeh Kamran Samani , avatar Hadi Akbari-Zadeh , avatar Fahimeh Aminolroayaei , avatar Ahmad Shanei , avatar Fariba Farhadi Birgani , avatar Fatemeh Maghsoudinia , *

Koomesh: Vol.25, issue 2; 135-144
published online: September 01, 2023
article type: Research Article
received: October 02, 2022
accepted: April 01, 2023

how to cite: Kamran Samani R, Akbari-Zadeh H, Aminolroayaei F, Shanei A, Farhadi Birgani F, et al. The Effect of Folic Acid-Targeted Nanocarriers in Ultrasound Imaging-guided Sonodynamic Therapy of Human Cervical Carcinoma (HeLa): in vitro Study. koomesh. 2023;25(2):e152811. 

Abstract

Introduction: Theranostic nanocarriers can be used simultaneously for the diagnosis and treatment of cancer. In this study, the effect of dotarem- and doxorubicin-loaded nanodroplet as a theranostic agent for ultrasound-guided and -controlled release drug delivery on HeLa cervical cancer cells was investigated. Materials and Methods: Folic acid-targeted nanodroplets consisting of dotarm (Gd-DOTA) and doxorubicin (DOX) with alginate shells were synthesized and characterized. In this study, HeLa and L929 cell lines were used as cancer and normal cells, respectively. Intracellular uptake of nanocarriers was evaluated using Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES). Doxorubicin release in response to ultrasound exposure and its effect on cancer treatment were investigated. Ultrasound imaging was performed to assess the ultrasound signal enhancement by nanodroplets. Results: The characterization results confirmed the successful synthesis of nanodroplets with desirable physicochemical properties. Cytotoxicity test showed that the synthesized nanodroplets had high biocompatibility for normal cells and induced more death in cancer cells (75.3% vs 62.1%). This effect was enhanced under ultrasound exposure (51%). The ICP-OES test showed that the uptake of Gd/DOX-loaded nanodroplets for sonicated cancer cells was approximately 1.5 times higher than that for non-sonicated cells after 12 h. The results showed that the ultrasound exposure significantly increased the doxorubicin release from nanodroplets (77.5% vs 2.1%). Also, ultrasound imaging showed that perfluorohexane nanodroplets could enhance ultrasound signal intensity. Conclusion: According to the results, doxorubicin- and dotarem-loaded nanodroplets with proper diagnostic and therapeutic properties can be promising theranostic agents in ultrasound-guided and controlled drug delivery for sonodynamic therapy of cancer.

References

  • 1.

    Shanei A, Abedi I, Saadatmand P, Amouheidari AR, Akbari-Zadeh H. Comparison of 3D conformal and intensity modulated radiotherapy in early stage oral tongue cancer: Dosimetric and radiobiological evaluation. Int J Radiat Res 2020; 18: 33-42.

  • 2.

    Dadashpour M, Ganjibakhsh M, Mousazadeh H, Nejati K. Increased pro-apoptotic and anti-proliferative activities of simvastatin encapsulated PCL-PEG Nanoparticles on human breast cancer adenocarcinoma cells. J Clust Sci 2022; 1-12.##https://doi.org/10.1007/s10876-021-02217-y.

  • 3.

    Mogheri F, Jokar E, Afshin R, Akbari AA, Dadashpour M, Firouzi-amandi A, et al. Co-delivery of metformin and silibinin in dual-drug loaded nanoparticles synergistically improves chemotherapy in human non-small cell lung cancer A549 cells. J Drug Deliv Sci Technol 2021; 66: 102752.##https://doi.org/10.1016/j.jddst.2021.102752.

  • 4.

    Franco YL, Vaidya TR, Ait-Oudhia S. Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer. Breast Cancer Targets Ther 2018; 10: 131.

  • 5.

    Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 2009; 16: 3267-3285.

  • 6.

    Shanei A, Akbari-Zadeh H. Investigating the sonodynamic-radiosensitivity effect of gold nanoparticles on HeLa cervical cancer cells. J Korean Med Sci 2019; 34.

  • 7.

    Maghsoudinia F, Akbari-Zadeh H, Aminolroayaei F, Birgani FF, Shanei A, Samani RK. Ultrasound responsive Gd-DOTA/doxorubicin-loaded nanodroplet as a theranostic agent for magnetic resonance image-guided controlled release drug delivery of melanoma cancer. Eur J Pharm Sci 2022; 106207.

  • 8.

    Jeyamogan S, Khan NA, Siddiqui R. Application and Importance of Theranostics in the Diagnosis and Treatment of Cancer. Arch Med Res 2021; 52: 131-142.

  • 9.

    Rengeng L, Qianyu Z, Yuehong L, Zhongzhong P, Libo L. Sonodynamic therapy, a treatment developing from photodynamic therapy. Photodiagnosis Photodyn Ther 2017; 19: 159-166.

  • 10.

    Shanei A, Akbari-Zadeh H, Attaran N, Salamat MR, Baradaran-Ghahfarokhi M. Effect of targeted gold nanoparticles size on acoustic cavitation: An in vitro study on melanoma cells. Ultrasonics 2019; 106061.

  • 11.

    Ninomiya K, Ogino C, Oshima S, Sonoke S, Kuroda S, Shimizu N. Targeted sonodynamic therapy using protein-modified TiO2 nanoparticles. Ultrason Sonochem 2012; 19: 607-614.

  • 12.

    Shanei A, Akbari-Zadeh H, Fakhimikabir H, Attaran N. The role of gold nanoparticles in sonosensitization of human cervical carcinoma cell line under ultrasound irradiation: an in vitro study. J Nano Res Trans Tech Publ 2019; p: 1-14.##https://doi.org/10.4028/www.scientific.net/JNanoR.59.1.

  • 13.

    Palekar-Shanbhag P, Jog S V, Chogale MM, Gaikwad SS. Theranostics for cancer therapy. Curr Drug Deliv 2013; 10: 357-362.

  • 14.

    Rostami A, Sazgarnia A. Gold nanoparticles as cancer theranostic agents. Nanomedicine J 2019; 6: 147-160.

  • 15.

    Azadeh SS, Rahmanian N. Letter to the Editor: Treatment of Covid-19 with Fisetin flavonoid nanoparticles. Koomesh 1401; 24: 283-287. (Persian).

  • 16.

    Akbari Jonoush Z, Mansori R, Yazdiyan F, Omidi M. Detection of prostate cancer biomarker using optical nanobiosensor based on gold nanoparticle. Koomesh 1396; 19: 774-784. (Persian).

  • 17.

    Elahi N, Kamali M, Baghersad MH. Recent biomedical applications of gold nanoparticles: a review. Talanta 2018.

  • 18.

    Maghsoudinia F, Tavakoli MB, Samani RK, Hejazi SH, Sobhani T, Mehradnia F, et al. Folic acid-functionalized gadolinium-loaded phase transition nanodroplets for dual-modal ultrasound/magnetic resonance imaging of hepatocellular carcinoma. Talanta 2021; 228: 122245.

  • 19.

    Pourgholi A, Dadashpour M, Mousapour A, Amandi AF, Zarghami N. Anticancer potential of silibinin loaded polymeric nanoparticles against breast cancer cells: insight into the apoptotic genes targets. Asian Pacific J Cancer Prev 2021; 22: 2587.

  • 20.

    Nejati K, Rastegar M, Fathi F, Dadashpour M, Arabzadeh A. Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance. J Drug Deliv Sci Technol 2022; 103231.##https://doi.org/10.1016/j.jddst.2022.103231.

  • 21.

    Salmani Javan E, Lotfi F, Jafari-Gharabaghlou D, Mousazadeh H, Dadashpour M, Zarghami N. Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: Possible action through leptin gene and its receptor regulation. Asian Pacific J Cancer Prev 2022; 23: 519-527.

  • 22.

    Pan X, Wang H, Wang S, Sun X, Wang L, Wang W, et al. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Sci China Life Sci 2018; 1-12.

  • 23.

    Shen S, Wu L, Liu J, Xie M, Shen H, Qi X, et al. Core-shell structured Fe3O4@ TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer. Int J Pharm 2015; 486: 380-388.

  • 24.

    Heng PW. Controlled release drug delivery systems. Pharm Dev Technol 2018; 23: 833.

  • 25.

    Sheeran PS, Dayton PA. Phase-change contrast agents for imaging and therapy. Curr Pharm Des 2012; 18: 2152-2165.

  • 26.

    Loskutova K, Grishenkov D, Ghorbani M. Review on acoustic droplet vaporization in ultrasound diagnostics and therapeutics. Biomed Res Int 2019; 2019.

  • 27.

    Vezeridis AM, Gracia C De, Barnhill SA, Kim S, Wu Z, Jin S, et al. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point. J Control Release 2019; 302: 54-62.

  • 28.

    Zhao N, Woodle MC, Mixson AJ. Advances in delivery systems for doxorubicin. J Nanomed Nanotechnol 2018; 9.

  • 29.

    Baghbani F, Chegeni M, Moztarzadeh F, Hadian-Ghazvini S, Raz M. Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: Curcumin. Mater Sci Eng C 2017; 74: 186-193.

  • 30.

    Meng D, Guo L, Shi D, Sun X, Shang M, Zhou X, et al. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. Nanomedicine 2019; 14: 2549-2565.

  • 31.

    Gu T, He F, Zhang Y, Hatton TA, Khan SA. Nanoemulsion meets droplet microfluidics: controlled mass transport and applications in micro-and nanoparticle preparation. 2018 AIChE Annu Meet AIChE 2018.

  • 32.

    Mortezazadeh T, Gholibegloo E, Riyahi Alam N, Dehghani S, Haghgoo S, Ghanaati H, et al. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. Magn Reson Mater Physics Biol Med 2019; 32: 487-500.

  • 33.

    Wang X, Shang M, Sun X, Guo L, Xiao S, Shi D, et al. Dual-responsive nanodroplets combined with ultrasound-targeted microbubble destruction suppress tumor growth and metastasis via autophagy blockade. J Control Release 2022; 343: 66-77.

  • 34.

    Wang P, Tang Q, Zhang L, Xu M, Sun L, Sun S, et al. Ultrasmall barium titanate nanoparticles for highly efficient hypoxic tumor therapy via ultrasound triggered piezocatalysis and water splitting. ACS Nano 2021; 15: 11326-11340.

  • 35.

    Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1: 2315-2319.

  • 36.

    Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed 2005; 16: 43-56.

  • 37.

    Kumari SDC, Tharani CB, Narayanan N, Kumar CS. Formulation and characterization of Methotrexate loaded sodium alginate chitosan Nanoparticles. Indian J Res Pharm Biotechnol 2013; 5674: 915-921.

  • 38.

    Liu G, Li DC, Li PP, Li RR, Chen SY. Nanoparticle methotrexate delivery system for the treatment of paediatric patients with inflammatory bowel disease. Biomed Res 2017; 28.

  • 39.

    Bajpai SK, Tankhiwale R. Investigation of dynamic release of vitamin B2 from calcium alginate/chitosan multilayered beads: Part II. React Funct Polym 2006; 66: 1565-1574.##https://doi.org/10.1016/j.reactfunctpolym.2006.05.007.

  • 40.

    Kripfgans OD, Fowlkes JB, Miller DL, Eldevik OP, Carson PL. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 2000; 26: 1177-1189.

  • 41.

    Ho YJ, Yeh CK. Theranostic performance of acoustic nanodroplet vaporization-generated bubbles in tumor intertissue. Theranostics 2017; 7: 1477-1488.

  • 42.

    Rapoport N. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012; 4: 492-510.